Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Wingett, Steven W."'
Autor:
Mielczarek, Olga, Rogers, Carolyn H., Zhan, Yinxiu, Matheson, Louise S., Stubbington, Michael J.T., Schoenfelder, Stefan, Bolland, Daniel J., Javierre, Biola M., Wingett, Steven W., Várnai, Csilla, Segonds-Pichon, Anne, Conn, Simon J., Krueger, Felix, Andrews, Simon, Fraser, Peter, Giorgetti, Luca, Corcoran, Anne E.
Publikováno v:
In Cell Reports 26 September 2023 42(9)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nützmann, Hans-Wilhelm, Doerr, Daniel, Ramírez-Colmenero, América, Sotelo-Fonseca, Jesús Emiliano, Wegel, Eva, Di Stefano, Marco, Wingett, Steven W., Fraser, Peter, Hurst, Laurence, Fernandez-Valverde, Selene L., Osbourn, Anne
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2020 Jun . 117(24), 13800-13809.
Externí odkaz:
https://www.jstor.org/stable/26968531
Autor:
Chun Hao Wong1,2, Wingett, Steven W.1, Chen Qian3, Hunter, Morag Rose2, Taliaferro, J. Matthew4, Ross-Thriepland, Douglas2 douglas.ross-thriepland@astrazeneca.com, Bullock, Simon L.1 sbullock@mrc-lmb.cam.ac.uk
Publikováno v:
Journal of Cell Biology. 5/6/2024, Vol. 223 Issue 5, p1-21. 32p.
Autor:
Pitera, Aleksandra P, Szaruga, Maria, Peak-Chew, Sew-Yeu, Wingett, Steven W, Bertolotti, Anne
Publikováno v:
The EMBO Journal. 41
Funder: EC | FP7 | FP7 Ideas: European Research Council (IDEE‐CER); Id: http://dx.doi.org/10.13039/100011199; Grant(s): FP7/(2007‐2013)/ERC grant 309516
Halofuginone (HF) is a phase 2 clinical compound that inhibits the glutamyl-prolyl-tRNA
Halofuginone (HF) is a phase 2 clinical compound that inhibits the glutamyl-prolyl-tRNA
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Furlan-Magaril, Mayra, Ando-Kuri, Masami, Arzate-Mejía, Rodrigo G., Morf, Jörg, Cairns, Jonathan, Román-Figueroa, Abraham, Tenorio-Hernández, Luis, Poot-Hernández, A. César, Andrews, Simon, Várnai, Csilla, Virk, Boo, Wingett, Steven W., Fraser, Peter
Additional file 4: Figure S4. TAD structure and CTCF binding is preserved during the 24 hours. A. TADs overlap between time points. B. TADs size distribution at all time points. C. 50kb resolution Median Observed/Expected Hi-C signal around 1000 rand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b981af4b7f393c0e0cce1ae6a86f681
Autor:
Furlan-Magaril, Mayra, Ando-Kuri, Masami, Arzate-Mejía, Rodrigo G., Morf, Jörg, Cairns, Jonathan, Román-Figueroa, Abraham, Tenorio-Hernández, Luis, Poot-Hernández, A. César, Andrews, Simon, Várnai, Csilla, Virk, Boo, Wingett, Steven W., Fraser, Peter
Additional file 7: Figure S7. Core clock gene promoter vs output circadian genes interaction landscapes.A-D. Virtual 4C for Rorc, Npas2, Nr1d2 and Per2, core clock circadian gene promoters from P-CHi-C data at all time points during the day. The Rorc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36c759f76d0c0fc481555c25a618f580
Autor:
Furlan-Magaril, Mayra, Ando-Kuri, Masami, Arzate-Mejía, Rodrigo G., Morf, Jörg, Cairns, Jonathan, Román-Figueroa, Abraham, Tenorio-Hernández, Luis, Poot-Hernández, A. César, Andrews, Simon, Várnai, Csilla, Virk, Boo, Wingett, Steven W., Fraser, Peter
Additional file 3: Figure S3. Expression profiles of the circadian genes displayed along the paper. RNA-seq signal tracks for circadian genes shown across the paper for the four timepoints during the circadian cycle. Arntl, Npas2, Cgn, Nr1d1, Dhrs3,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::030e50fb4e8c3fde8ce7871175c02de7
Autor:
Furlan-Magaril, Mayra, Ando-Kuri, Masami, Arzate-Mejía, Rodrigo G., Morf, Jörg, Cairns, Jonathan, Román-Figueroa, Abraham, Tenorio-Hernández, Luis, Poot-Hernández, A. César, Andrews, Simon, Várnai, Csilla, Virk, Boo, Wingett, Steven W., Fraser, Peter
Additional file 6: Figure S6. Circadian gene promoter-promoter interactions. A. Promoter-promoter contact network at ZT0 with the circadian genes marked in blue. B. Above, number of edges (interactions) between circadian gene promoters at ZT0, 6, 12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e9194f78607126e994017e777ba6af2